Clinical Trial Update: A Phase Ib/II Study to Investigate the Safety of SHR-1819 in Children and Adolescents With Moderate-to-severe Atopic Dermatitis [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study evaluating the safety of SHR-1819 in children and adolescents with moderate-to-severe atopic dermatitis; the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• SHR-1819

Snippet

Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd | Conditions: Children and Adolescents With Moderate-to-severe Atopic Dermatitis | Phase 1, Phase 2 | Status: RECRUITING